INS and diabetes mellitus: When administered after induction of diabetes with low-dose STZ, ABA ameliorated the efficacy of residual endogenous insulin on glycemia, resulting in a significantly reduced glycemia profile in the treated animals (Figure 1D), and also improved the response to exogenous low-dose insulin (Figure 1E).